Work across varying therapeutic areas and new technology among reasons why CROs are qualified to advance model.
Art Brown
Advertisement
Director of Product Marketing, LifeSphere Clinical at ArisGlobal
Articles by Art Brown
Advertisement
Latest Updated Articles
How CROs are Uniquely Positioned to Drive Adoption of the TMF Exchange MechanismPublished: July 14th 2022 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Integrating AI Across Legacy Clinical Trial Systems
2
Reimagining Clinical Operations Through Artificial Intelligence
3
Balancing Human Oversight and Automation in AI-Driven Trials
4
Preparation Tips to Minimize Impact of Regulatory Inspections for IRT Systems
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
